Literature DB >> 2560183

Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance.

M Ivarsson1, A Neil.   

Abstract

We have compared the effectiveness of morphine and methadone as agonists in untreated guinea-pig longitudinal muscle preparations and after their treatment with the specific opioid receptor alkylating agent beta-chloronaltrexamine. In untreated ilea, the naloxone pA2 was 8.5 to both morphine and methadone, and their dose-response curves were parallel. After alkylation, the dose-response curve for morphine was shifted to the right with a decreased maximal effect. It was found that about 70% of the receptors were inactivated by the treatment, corresponding to a morphine receptor occupancy at IC50 of about 24%. The maximal effect of methadone was not decreased by the same beta-chloronaltrexamine treatment, indicating a much higher efficacy or receptor reserve for the drug. The possibility that differences in efficacies could account for previously reported heterogeneities in actions of opioids, such as assymmetries in cross-tolerance towards morphine and methadone in experimental animal and man, is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560183     DOI: 10.1111/j.1600-0773.1989.tb01190.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  3 in total

1.  Opioid plasma concentration during switching from morphine to methadone: preliminary data.

Authors:  S Mercadante; M Bianchi; P Villari; P Ferrera; A Casuccio; F Fulfaro; V Gebbia
Journal:  Support Care Cancer       Date:  2003-04-03       Impact factor: 3.603

2.  Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.

Authors:  Michael Wallisch; Cole S Nelson; Julia M Mulvaney; Heather S Hernandez; Sue Ann Smith; George D Olsen
Journal:  Biochem Pharmacol       Date:  2007-02-12       Impact factor: 5.858

3.  A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study.

Authors:  Fabian Heuser; Christian M Schulz; Alexander Hapfelmeier; Nadine Lehnen; Eberhard F Kochs; Klaus J Wagner
Journal:  BMC Anesthesiol       Date:  2016-10-10       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.